Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis.
about
Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action.2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.Systems proteomics approaches to study bacterial pathogens: application to Mycobacterium tuberculosis.Mycobacterial Response to Organic Solvents and Possible Implications on Cross-Resistance With Antimicrobial Agents.Potential Alternative Strategy against Drug Resistant Tuberculosis: A Proteomics Prospect.
P2860
Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis.
@en
type
label
Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis.
@en
prefLabel
Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis.
@en
P2093
P50
P1476
Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis.
@en
P2093
Arnoud H de Ru
Arnout Mulder
Evy M Heerkens
Jeroen de Keijzer
Petra E W de Haas
P304
P356
10.1021/ACS.JPROTEOME.5B01037
P577
2016-04-11T00:00:00Z